Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Akero Therapeutics, Inc. (AKRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G BAKER BROS. ADVISORS LP reports a 5.1% stake in Akero Therapeutics, Inc.
02/14/2023 SC 13G PRICE T ROWE ASSOCIATES INC reports a 5.1% stake in AKERO THERAPEUTICS INC
02/03/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 SC 13G BlackRock Inc. reports a 5.9% stake in Akero Therapeutics, Inc.
11/09/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/16/2022 SC 13G Avidity Partners Management LP reports a 6.9% stake in Akero Therapeutics, Inc.
06/28/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/04/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/04/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/13/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/30/2021 SC 13G Skorpios Trust reports a 14.1% stake in Akero Therapeutics, Inc.
02/16/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/11/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/07/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/05/2019 SC 13G Versant Venture Capital VI, L.P. reports a 14.7% stake in Akero Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy